Two New Studies Show Quercetin Improves C***D Outcomes
Nov 25, 2021 02:24:22 #
https://flybynews.wordpress.com/2021/10/14/two-new-studies-show-quercetin-improves-c***d-outcomes/
Analysis by Dr. Joseph MercolaFact Checked
*Two recently published studies confirm quercetin is useful as an adjunct therapy in the early outpatient treatment of mild SARS-CoV-2 infection
*In one study, C***D patients who received quercetin in addition to analgesics and an antibiotic cleared the v***s faster than those who only received analgesics and antibiotics, and a greater number of patients reported reduced symptoms
*In the second study, daily quercetin supplementation for one month reduced the frequency and length of hospitalization, the need for noninvasive oxygen therapy, intensive care and deaths
*Quercetin has antiv***l, anti-blood clotting, anti-inflammatory and antioxidant properties, all of which are important in the treatment of SARS-CoV-2 infection
*Quercetin also inhibits binding of specific spike proteins to your ACE2 receptors, thereby blocking the v***s’ ability to infect your cells. It’s also been shown to directly neutralize v***l proteins that are critical in the replication of SARS‐CoV‐2
In an August 21, 2021, newsletter,1 Dr. Michael Murray discussed the use of quercetin for respiratory infection symptoms. In November 2020, he’d suffered a “very mild and brief bout of C****-**,” and one of his “secret weapons,” he believes, might have been quercetin.
He also recounts an anecdotal story of a friend who developed suspicious respiratory symptoms. His friend had been taking a number of supplements said to offer protection, but was still feeling awful.
As it turns out, the one thing he’d not taken was quercetin, and as soon as he did, that same day, his symptoms started to dissipate. This experience, Murray says, “is consistent with the results from two clinical trials” that were recently published.
Quercetin seems to be a safe, far less expensive, and easier-to-obtain alternative to hydroxychloroquine, and it works by a similar mechanism, driving zinc into the cells to stop v***l replication.
Statistical Improvement in Clinical Outcomes
In the first study,2 42 C****-** outpatients were divided into two groups. One group of 21 patients received standard medical therapy consisting of analgesics and an antibiotic (acetaminophen 500-milligram (mg) to 1,000-mg dose if body temperature was higher than 37.5 degrees C — 99.5 F — with a maximum daily dosage of 3 grams, and 500 mg azithromycin for three consecutive days).
The other group of 21 patients received standard therapy plus the equivalent of 600 mg of quercetin per day (divided into three doses) for seven days, followed by another seven-day course of 400 mg of quercetin per day (divided into two doses).
The quercetin used was a brand name formulated with sunflower lecithin, which has been demonstrated to increase absorption in the gut by as much as 20 times, compared to pure quercetin formulations.
The main outcomes being evaluated were v***s clearance and symptoms. After one week of treatment, 16 of the 21 patients in the quercetin group tested negative for SARS-CoV-2 and 12 reported that all symptoms had diminished.
In the standard care group, only two tested negative and four had partially improved symptoms. By the end of Week 2, the five remaining patients in the quercetin group tested negative. In the standard care group, 17 of the 19 remaining patients tested negative and one had died.
As noted by the authors, quercetin supplementation “statistically shortens the timing of molecular test conversion from positive to negative, reducing at the same time symptoms severity and negative predictors of C****-**.”
“These results are impressive and hopefully additional studies will be conducted on hospitalized patients to see how quercetin might be helpful in more severe cases,” Murray wrote in his newsletter.
Quercetin Reduces Hospitalizations and Deaths
The second study3 — a prospective, randomized, controlled and open-label trial — gave 152 C****-** outpatients a daily dose of 1,000 mg of quercetin for 30 days to evaluate its adjuvant effects in the treatment of early symptoms and the prevention of severe infection. According to the authors:
“The results revealed a reduction in frequency and length of hospitalization, in need of non-invasive oxygen therapy, in progression to intensive care units and in number of deaths. The results also confirmed the very high safety profile of quercetin and suggested possible anti-fatigue and pro-appetite properties.
QP (Quercetin Phytosome®) is a safe agent and in combination with standard care, when used in early stage of v***l infection, could aid in improving the early symptoms and help in preventing the severity of C****-** disease. It is suggested that a double-blind, placebo-controlled study should be urgently carried out to confirm the results of our study.”
con't
Analysis by Dr. Joseph MercolaFact Checked
*Two recently published studies confirm quercetin is useful as an adjunct therapy in the early outpatient treatment of mild SARS-CoV-2 infection
*In one study, C***D patients who received quercetin in addition to analgesics and an antibiotic cleared the v***s faster than those who only received analgesics and antibiotics, and a greater number of patients reported reduced symptoms
*In the second study, daily quercetin supplementation for one month reduced the frequency and length of hospitalization, the need for noninvasive oxygen therapy, intensive care and deaths
*Quercetin has antiv***l, anti-blood clotting, anti-inflammatory and antioxidant properties, all of which are important in the treatment of SARS-CoV-2 infection
*Quercetin also inhibits binding of specific spike proteins to your ACE2 receptors, thereby blocking the v***s’ ability to infect your cells. It’s also been shown to directly neutralize v***l proteins that are critical in the replication of SARS‐CoV‐2
In an August 21, 2021, newsletter,1 Dr. Michael Murray discussed the use of quercetin for respiratory infection symptoms. In November 2020, he’d suffered a “very mild and brief bout of C****-**,” and one of his “secret weapons,” he believes, might have been quercetin.
He also recounts an anecdotal story of a friend who developed suspicious respiratory symptoms. His friend had been taking a number of supplements said to offer protection, but was still feeling awful.
As it turns out, the one thing he’d not taken was quercetin, and as soon as he did, that same day, his symptoms started to dissipate. This experience, Murray says, “is consistent with the results from two clinical trials” that were recently published.
Quercetin seems to be a safe, far less expensive, and easier-to-obtain alternative to hydroxychloroquine, and it works by a similar mechanism, driving zinc into the cells to stop v***l replication.
Statistical Improvement in Clinical Outcomes
In the first study,2 42 C****-** outpatients were divided into two groups. One group of 21 patients received standard medical therapy consisting of analgesics and an antibiotic (acetaminophen 500-milligram (mg) to 1,000-mg dose if body temperature was higher than 37.5 degrees C — 99.5 F — with a maximum daily dosage of 3 grams, and 500 mg azithromycin for three consecutive days).
The other group of 21 patients received standard therapy plus the equivalent of 600 mg of quercetin per day (divided into three doses) for seven days, followed by another seven-day course of 400 mg of quercetin per day (divided into two doses).
The quercetin used was a brand name formulated with sunflower lecithin, which has been demonstrated to increase absorption in the gut by as much as 20 times, compared to pure quercetin formulations.
The main outcomes being evaluated were v***s clearance and symptoms. After one week of treatment, 16 of the 21 patients in the quercetin group tested negative for SARS-CoV-2 and 12 reported that all symptoms had diminished.
In the standard care group, only two tested negative and four had partially improved symptoms. By the end of Week 2, the five remaining patients in the quercetin group tested negative. In the standard care group, 17 of the 19 remaining patients tested negative and one had died.
As noted by the authors, quercetin supplementation “statistically shortens the timing of molecular test conversion from positive to negative, reducing at the same time symptoms severity and negative predictors of C****-**.”
“These results are impressive and hopefully additional studies will be conducted on hospitalized patients to see how quercetin might be helpful in more severe cases,” Murray wrote in his newsletter.
Quercetin Reduces Hospitalizations and Deaths
The second study3 — a prospective, randomized, controlled and open-label trial — gave 152 C****-** outpatients a daily dose of 1,000 mg of quercetin for 30 days to evaluate its adjuvant effects in the treatment of early symptoms and the prevention of severe infection. According to the authors:
“The results revealed a reduction in frequency and length of hospitalization, in need of non-invasive oxygen therapy, in progression to intensive care units and in number of deaths. The results also confirmed the very high safety profile of quercetin and suggested possible anti-fatigue and pro-appetite properties.
QP (Quercetin Phytosome®) is a safe agent and in combination with standard care, when used in early stage of v***l infection, could aid in improving the early symptoms and help in preventing the severity of C****-** disease. It is suggested that a double-blind, placebo-controlled study should be urgently carried out to confirm the results of our study.”
con't
If you want to reply, then register here. Registration is free and your account is created instantly, so you can post right away.